メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学部
藤田医科大学
概要
フィンガープリント
ネットワーク
プロファイル
(467)
研究成果
(10719)
フィンガープリント
医学部が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Neoplasm
100%
Surgery
80%
Disease
63%
Stomach Cancer
58%
Aneurysm
55%
Computer Assisted Tomography
54%
Malignant Neoplasm
50%
Cohort Analysis
46%
Hepatectomy
44%
Percutaneous Coronary Intervention
44%
Apoplexy
42%
Recurrent Disease
36%
Colorectal Cancer
36%
Bleeding
35%
COVID-19
35%
Infection
34%
Odds Ratio
34%
Overall Survival
33%
Hazard Ratio
33%
Gastrectomy
32%
Magnetic Resonance Imaging
28%
Retrospective Study
28%
Observational Study
28%
Survival Rate
28%
Diagnosis
27%
Systematic Review
26%
Artery
25%
Chronic Kidney Disease
25%
Meta-Analysis
24%
Brain Artery Aneurysm
24%
Metastatic Carcinoma
22%
Prognostic Factor
22%
Symptom
21%
Hepatocellular Carcinoma
21%
Cardiovascular System
21%
Body Mass Index
21%
Surgeon
21%
Acute Coronary Syndrome
20%
Intravascular Ultrasound
20%
Rectum Cancer
20%
Prevalence
20%
Pediatrics
20%
Lung Cancer
20%
Coronary Artery Disease
20%
Multivariate Analysis
20%
Retroperitoneal Lymph Node Dissection
19%
Pancreas Transplantation
19%
Endoscopic Ultrasound
19%
Heart Failure
18%
Adverse Event
18%
Breast Cancer
18%
Pancreas Cancer
18%
Adenocarcinoma
18%
Glomerular Filtration Rate
17%
C Reactive Protein
17%
Diabetes Mellitus
17%
Liver Metastasis
17%
Clinical Trial
17%
Hemodialysis
17%
Stenosis
17%
Myocardial Infarction
16%
Acute Heart Infarction
16%
Cancer
16%
Prospective Study
16%
Operation Duration
16%
Lymph Node Metastasis
15%
Rehabilitation Engineering
15%
Surgical Anastomosis
15%
Neck
15%
Biopsy
15%
Kidney Function
15%
Cardiovascular Disease
15%
Diabetes
14%
Carcinoma
14%
Non Small Cell Lung Cancer
13%
Proportional Hazards Model
13%
Clinical Feature
13%
Prospective Cohort Study
13%
Postoperative Complication
13%
Computed Tomography Angiography
13%
Subarachnoid Hemorrhage
13%
Optical Coherence Tomography
12%
Biological Marker
12%
Creatinine
12%
Intensive Care Unit
12%
Pancreaticoduodenectomy
12%
Atrial Fibrillation
12%
Plummer-Vinson Syndrome
12%
Retrospective Cohort Study
12%
Surgical Technique
12%
ST Segment Elevation Myocardial Infarction
12%
Proteinuria
12%
Cross Sectional Study
12%
Lymph Node
12%
Drug-Eluting Stent
11%
Sepsis
11%
Endoscopy
11%
Randomized Controlled Trial
11%
Arm
11%
Urinary System
11%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
84%
Chemotherapy
50%
Cohort Study
48%
Stomach Cancer
46%
Malignant Neoplasm
42%
Infection
39%
Adverse Event
35%
Neoplasm
34%
Colorectal Cancer
31%
Cardiovascular Disease
30%
Overall Survival
28%
Placebo
25%
Mouse
25%
Lung Cancer
24%
C Reactive Protein
23%
Symptom
23%
Prevalence
22%
Acute Heart Infarction
21%
Clinical Trial
21%
Inflammation
20%
Randomized Controlled Trial
19%
Lipopolysaccharide
19%
Coronary Artery Disease
19%
Heart Failure
19%
Observational Study
19%
Hemodialysis
18%
All Cause Mortality
18%
Prospective Study
18%
Heart Infarction
17%
Remission
17%
Recurrent Disease
17%
Liver Cell Carcinoma
17%
Combination Therapy
16%
Bleeding
16%
Atrial Fibrillation
16%
Progression Free Survival
15%
Chronic Kidney Failure
15%
Retrospective Study
15%
Biological Marker
15%
Survival Rate
15%
Acute Coronary Syndrome
15%
Non Small Cell Lung Cancer
15%
Diabetes Mellitus
14%
Coronavirinae
14%
Aneurysm
13%
Pancreas Cancer
13%
Sepsis
13%
Prospective Cohort Study
13%
Cytokine
13%
Ischemic Heart Disease
12%
Statin (Protein)
12%
Human Herpesvirus 6
12%
Epidermal Growth Factor Receptor
12%
Monotherapy
11%
Antipsychotic
11%
ST Segment Elevation Myocardial Infarction
11%
Asthma
11%
Syndrome
11%
Cisplatin
11%
Cancer Mortality
10%
Case-Control Study
10%
Hospital Mortality
10%
Fluorouracil
10%
Pitavastatin
9%
Creatinine
9%
Adiponectin
9%
Liver Metastasis
9%
Non Insulin Dependent Diabetes Mellitus
9%
Vaccination Policy
9%
Typical Antipsychotic
9%
Aripiprazole
9%
Carcinogenesis
8%
Clinical Study
8%
Rituximab
8%
Antiplatelet
8%
Alzheimer's Disease
8%
Subarachnoid Hemorrhage
8%
Metabolic Syndrome X
8%
Helicobacter Pylori
8%
Tumor Necrosis Factor
8%
Clinical Feature
8%
Brain Artery Aneurysm
8%
Obesity
8%
Atherosclerosis
8%
Breast Cancer
7%
High Density Lipoprotein Cholesterol
7%
Mortality Rate
7%
Normal Human
7%
Stomach Carcinoma
7%
Heart Death
7%
Comorbidity
7%
Brain Natriuretic Peptide
7%
Brain Ischemia
7%
Low Density Lipoprotein Cholesterol
7%
Paclitaxel
7%
Everolimus
7%
Epileptic Absence
7%
Immune Checkpoint Inhibitor
7%
Crohn's Disease
7%
Peripheral Occlusive Artery Disease
7%
Keyphrases
Japan
52%
Confidence Interval
21%
Gastric Cancer
13%
Japanese Patients
12%
Hazard Ratio
12%
Japanese Population
11%
Clinical Outcomes
11%
Percutaneous Coronary Intervention
11%
Chemotherapy
9%
Odds Ratio
9%
Tumor
9%
Overall Survival
9%
Lipopolysaccharide
8%
Pancreas Transplantation
8%
Risk Factors
8%
Meta-analysis
8%
Acute Myocardial Infarction
7%
Lipopolysaccharide-induced
7%
Genotype
7%
Human Herpesvirus 6 (HHV-6)
7%
Major Depressive Disorder
7%
Schizophrenia
7%
Colorectal Cancer
7%
Non-small Cell Lung Cancer (NSCLC)
7%
Ulcerative Colitis
6%
Body Mass Index
6%
Gastric Carcinoma
6%
Japanese Workers
6%
5-fluorouracil (5-FU)
6%
Nitric Oxide Production
6%
Liver
5%
Multivariate Analysis
5%
Polymorphism
5%
Acute Coronary Syndrome
5%
Hemodialysis Patients
5%
Prognostic Factors
5%
COVID-19
5%
Pancreatic Cancer
5%
Rotavirus
5%
Metabolic Syndrome
5%
No Significant Difference
5%
Helicobacter Pylori (H. pylori)
5%
Tumor Necrosis Factor-α
5%